Self-rated health, β-blockers and adverse events.
Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. Electronic address: mitja.lainscak@guest.arnes.si.
Mitja
M
Lainscak
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany; Center for Clinical Studies, University Hospital Würzburg, Würzburg, Germany.
Götz
G
Gelbrich
Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany.
Hans-Dirk
HD
Düngen
Chair of Public Health, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Jerneja
J
Farkas
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D005260:Female; D006304:Health Status; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D057566:Self Report / Q000592:standards
D000319:Adrenergic beta-Antagonists
Beta-blockers; Heart failure; Self-rated health